RESEARCH

A Centre of Excellence for ME

Invest in ME Research - an independent UK charity

Building a solid foundation for future biomedical research into ME.

"....with the other expertise and facilities located at the Norwich Research Park, puts it in a very good position to lead a UK and European Centre of Excellence for biomedical research for M.E. to provide possible prevention and solutions."

- Professor Ian Charles Director of Institute of Food Research and Head of Quadram Institute

THE RESEARCH

With the help of leading researchers the charity is proposing a number of initial projects which would help establish a research base and lead to further projects being initiated based on findings.

It is not often realised that 60-70% of the immune system is located in the gut as a vast network of lymph tissue referred to as GALT (gut associated lymphatic tissue). The research highlighted in the proposal involves looking at gut microbiota, which is the latest thinking in how to go about research. In USA, renowned pathogen hunter Dr. Ian Lipkin and specialist clinician Dr. Nancy Klimas have suggested a similar approach.

There are also a number of new ideas being developed and collaboration between researchers at universities in UK and Europe and USA is underway thanks to the initiatives of the charity and researchers.

The aim is to build on this but the research has to start somewhere and so the researchers have begun afresh with the best approach. This research proposal is to build a strategy of biomedical research which would involve patients, clinicians and researchers working together.

A foundation project at the University of East Anglia began in 2013 - funded by Invest in ME Research. More details are available at this link.

Further projects are underway in Norwich Research Park - more details here.

The charity had been keen to replicate the Norwegian findings (click here) using Rituximab. We initiated B-cell research at UCL which would have led to a UK rituximab clinical trial. A specific web site was set up to document this project - see www.ukrituximabtrial.org.
Dr Oystein Fluge and his team from Haukeland University Hospital in Bergen, Norway, visited Norwich in January 2017 to collaborate with the researchers from University of East Anglia/Quadram Institute Biosience/University College London/Oxford University - details here.
The Norwegian Phase III rituximab trial proved negative inthe end but useful research and collaborations have resulted.

Our strategy also includes European and international collaboration.
The charity has spent many years attempting to cultivate international collaboration with research into ME. We have facilitated the formation of the European ME Research Group (EMERG) as a way of fast tracking European research - more details here.

Our anual research colloquiums are also aimed at increasing collaboration and regularly attract delegates from 14 countries - more details here.

We welcome support to help us build a Centre of Excellence for ME - ways to help are to the right of this page.

Our Current Projects




Researchers Comments